Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 3 of 3
Full-Text Articles in Entire DC Network
Oncolog, Volume 62, Number 08, August 2017, Bryan Tutt, Sarah Bronson
Oncolog, Volume 62, Number 08, August 2017, Bryan Tutt, Sarah Bronson
OncoLog MD Anderson's Report to Physicians (All issues)
- Immunotherapy for Smoldering Myeloma: Clinical trials test PD-1, DC38 inhibitors to delay progression from premalignant disease to multiple myeloma.
- Malignant Pheochromocytoma and Sympathetic Paraganglioma Research: Studies may expand treatment options for patients with rare neuroendocrine tumors.
- Hypofractionated Partial-Breast Irradiation: Clinical trial tests 10-day external-beam radiation therapy regimen after lumpectomy for patients with early-stage breast cancer.
- HOUSE CALL: Support for Cancer Patients: Patients, caregivers find many types of support from various organizations
Oncolog, Volume 62, Number 02, February 2017, Jill Deisigne-Russell, Christina Bennett, Laura Russell
Oncolog, Volume 62, Number 02, February 2017, Jill Deisigne-Russell, Christina Bennett, Laura Russell
OncoLog MD Anderson's Report to Physicians (All issues)
- Fallopian Tube Removal May Reduce Ovarian Cancer Risk: Alternative approach to prophylactic surgery for women with BRCA mutations averts early menopause.
- Highlights from the 2016 San Antonio Breast Cancer Symposium: MD Anderson researchers present findings regarding diagnosis, staging, treatment.
- INBRIEF: Locoregional Restaging of Newly Diagnosed Breast Cancer with Mammography and Ultrasonography May Help Detect Additional Lesions
- HOUSE CALL: Stem Cell Transplant Terms: Helpful definitions for patients and families
- USEFUL RESOURCES: Algorithms for Managing Treatment-Related Conditions
Oncolog, Volume 62, Number 01, January 2017, Bryan Tutt, Joe Munch, Z Ahmed
Oncolog, Volume 62, Number 01, January 2017, Bryan Tutt, Joe Munch, Z Ahmed
OncoLog MD Anderson's Report to Physicians (All issues)
- Neoadjuvant Immunotherapy for Melanoma: Trial investigates immune checkpoint blockade in patients with respectable stage III or oligometastatic stage IV disease.
- Radiation May Enhance Immunotherapy for Solid Tumors: Clinical Trials combine immune checkpoint inhibitors with radiation therapy against lung cancers, other solid tumors.
- INBRIEF: Nivolumab Plus Azacitidine Shows Promise in Relapsed Acute Myelogenous Leukemia/ Acute Myelogenous Leukemia, Myelodysplastic Syndrome Study Questions Standard Exclusion Criteria for Conventional Trials
- HOUSE CALL: Social Media Groups for Cancer Patients-Twitter chats, online groups for patients, caregivers
- USEFUL RESOURCES: Resources to Aid Referring Physicians